NCT02156492View on ClinicalTrials.gov

A Study of Evacetrapib With Selected Statins in Healthy Chinese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

Evacetrapib

Administered orally.

DRUG

Simvastatin

Administered orally.

DRUG

Atorvastatin

Administered orally.

Trial Locations (1)

100034

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Beijing

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02156492 - A Study of Evacetrapib With Selected Statins in Healthy Chinese Participants | Biotech Hunter | Biotech Hunter